Tri Locum Partners LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$482.7B
Holdings
28
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TEVATEVA PHARMACEUTICAL INDS LTD | 2,423,116 | $53.4B | 11.06% | |
| 2 | ZBHZIMMER BIOMET HOLDINGS INC | 369,004 | $39.0B | 8.07% | |
| 3 | ARGXARGENX SE | 58,258 | $35.8B | 7.42% | |
| 4 | NTRANATERA INC | 202,646 | $32.1B | 6.65% | |
| 5 | INSPINSPIRE MED SYS INC | 150,788 | $28.0B | 5.79% | |
| 6 | STVNSTEVANATO GROUP S P A | 1,121,804 | $24.4B | 5.06% | |
| 7 | AXSMAXSOME THERAPEUTICS INC | 249,769 | $21.1B | 4.38% | |
| 8 | VRNAVERONA PHARMA PLC | 454,201 | $21.1B | 4.37% | |
| 9 | AVDLAVADEL PHARMACEUTICALS PLC | 1,937,984 | $20.4B | 4.22% | |
| 10 | BMYBRISTOL-MYERS SQUIBB CO | 355,366 | $20.1B | 4.16% | |
| 11 | JAZZJAZZ PHARMACEUTICALS PLC | 161,812 | $19.9B | 4.13% | |
| 12 | IDXXIDEXX LABS INC | 44,972 | $18.6B | 3.85% | |
| 13 | NVONOVO-NORDISK A S | 209,984 | $18.1B | 3.74% | |
| 14 | MDGLMADRIGAL PHARMACEUTICALS INC | 47,472 | $14.6B | 3.03% | |
| 15 | MRUSMERUS N V | 347,303 | $14.6B | 3.03% | |
| 16 | UNHUNITEDHEALTH GROUP INC | 28,115 | $14.2B | 2.95% | |
| 17 | JANXJANUX THERAPEUTICS INC | 236,407 | $12.7B | 2.62% | |
| 18 | LEGNLEGEND BIOTECH CORP | 388,704 | $12.6B | 2.62% | |
| 19 | CITHE CIGNA GROUP | 40,810 | $11.3B | 2.33% | |
| 20 | WGSGENEDX HOLDINGS CORP | 127,567 | $9.8B | 2.03% | |
| 21 | GONGERON CORP | 2,472,836 | $8.8B | 1.81% | |
| 22 | EOLSEVOLUS INC | 742,574 | $8.2B | 1.70% | |
| 23 | BRD1EURMIND MEDICINE MINDMED INC | 820,793 | $5.7B | 1.18% | |
| 24 | KRROKORRO BIO INC | 144,216 | $5.5B | 1.14% | |
| 25 | BHVNBIOHAVEN LTD | 140,220 | $5.2B | 1.08% | |
| 26 | LIVNLIVANOVA PLC | 99,700 | $4.6B | 0.96% | |
| 27 | PRAXPRAXIS PRECISION MEDICINES I | 37,269 | $2.9B | 0.59% | |
| 28 | FEMYFEMASYS INC | 30,606 | $33.7M | 0.01% |